|
FASTKD3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.500800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.523800E-01 |
| Normal-vs-Stage2 |
6.735800E-01 |
| Normal-vs-Stage3 |
5.269000E-01 |
| Normal-vs-Stage4 |
7.360800E-01 |
| Stage1-vs-Stage2 |
9.883400E-01 |
| Stage1-vs-Stage3 |
9.686600E-01 |
| Stage1-vs-Stage4 |
2.171400E-01 |
| Stage2-vs-Stage3 |
9.702200E-01 |
| Stage2-vs-Stage4 |
5.132400E-01 |
| Stage3-vs-Stage4 |
3.250400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.308800E-01 |
| Normal-vs-AfricanAmerican |
3.877200E-01 |
| Normal-vs-Asian |
9.243400E-01 |
| Caucasian-vs-AfricanAmerican |
1.520000E-01 |
| Caucasian-vs-Asian |
7.761400E-01 |
| AfricanAmerican-vs-Asian |
6.324400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.584000E-01 |
| Normal-vs-Female |
2.477600E-01 |
| Male-vs-Female |
1.988420E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.413800E-02 |
| Normal-vs-Age(41-60Yrs) |
7.833200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.556600E-01 |
| Normal-vs-Age(81-100Yrs) |
1.284840E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.126400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.918800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.199200E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.345800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.465600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.213800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.858400E-01 |
| Normal-vs-Grade 2 |
2.142000E-01 |
| Normal-vs-Grade 3 |
4.217400E-01 |
| Normal-vs-Grade 4 |
2.824000E-02 |
| Grade 1-vs-Grade 2 |
3.117200E-01 |
| Grade 1-vs-Grade 3 |
5.423600E-01 |
| Grade 1-vs-Grade 4 |
1.113760E-01 |
| Grade 2-vs-Grade 3 |
5.455800E-01 |
| Grade 2-vs-Grade 4 |
2.207100E-04 |
| Grade 3-vs-Grade 4 |
2.353100E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.225000E-03 |
| Normal-vs-ccB subtype |
1.187420E-01 |
| ccA subtype-vs-ccB subtype |
1.12379999994694E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.388200E-01 |
| Normal-vs-N1 |
2.357600E-01 |
| N0-vs-N1 |
5.473900E-02 |
|
|
